Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.950
+0.040 (2.09%)
Aug 3, 2026, 1:44 PM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $697.26 million as of August 3, 2026. Its market cap has decreased by -53.66% in one year.
Market Cap
697.26M
Enterprise Value
631.34M
1-Year Change
-53.66%
Ranking
Category
Stock Price
$1.95
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $697.26M, a decrease of -92.41%. That is a compound annual growth rate of -41.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 697.26M | -38.67% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.15B |
| Cronos Group | 1.05B |
| Pacira BioSciences | 1.04B |
| Amphastar Pharmaceuticals | 879.21M |
| Glass House Brands | 810.77M |
| Ironwood Pharmaceuticals | 696.31M |
| Tilray Brands | 615.69M |
| Aquestive Therapeutics | 463.60M |